Institutional Ownership Arbutus Biopharma Corp (ABUS)
This table provides information about the institutional ownership of Arbutus Biopharma Corp (ABUS). We have compiled data on the 138 institutions that hold shares in the stock, with a total of 95.4 Million shares, which have been reported (via 13F filing form) to have a value of $376 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Lindbrook Capital, LLC
|
Jul 31, 2024 Q2 2024 |
284
shares
|
$1,118
0.0% of portfolio
|
Q4 2023
New holding
|
|
Private Wealth Management Group, LLC
Princeton, NJ |
Oct 29, 2024 Q3 2024 |
242
shares
|
$953
0.0% of portfolio
|
Q4 2023
New holding
|
|
Gamma Investing LLC
Foster City, CA |
Oct 04, 2024 Q3 2024 |
187
shares
|
$736
0.0% of portfolio
|
Q4 2023
New holding
|
|
Lake Point Wealth Management
|
Jul 19, 2022 Q2 2022 |
100
shares
|
$394
0.0% of portfolio
|
Q4 2021
New holding
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|